大麻二酚（CBD）与Δ⁹-四氢大麻酚（THC）之间的相互作用：大麻素给药间隔和剂量比的影响 - Suppr

Suppr

超能文献

Interaction between cannabidiol (CBD) and ∆(9)-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids.

作者信息

Zuardi Antonio Waldo, Hallak Jaime Eduardo Cecílio, Crippa José Alexandre S

出版信息

Psychopharmacology (Berl). 2012 Jan;219(1):247-9. doi: 10.1007/s00213-011-2495-x. Epub 2011 Sep 21.

DOI:10.1007/s00213-011-2495-x

PMID:21947314

Abstract

摘要

相似文献

Interaction between cannabidiol (CBD) and ∆(9)-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids.

Psychopharmacology (Berl). 2012 Jan;219(1):247-9. doi: 10.1007/s00213-011-2495-x. Epub 2011 Sep 21.

Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.

Braz J Med Biol Res. 1983 Jul;16(2):141-6.

Effects of daily Δ-Tetrahydrocannabinol (THC) alone or combined with cannabidiol (CBD) on cognition-based behavior and activity in adolescent nonhuman primates.

Drug Alcohol Depend. 2021 Apr 1;221:108629. doi: 10.1016/j.drugalcdep.2021.108629. Epub 2021 Feb 17.

The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys.

Psychopharmacology (Berl). 1980;72(1):21-6. doi: 10.1007/BF00433803.

Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.

Psychopharmacology (Berl). 2011 Nov;218(2):443-57. doi: 10.1007/s00213-011-2342-0. Epub 2011 Jun 11.

How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review.

Neurosci Biobehav Rev. 2019 Dec;107:696-712. doi: 10.1016/j.neubiorev.2019.09.036. Epub 2019 Sep 30.

A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.

Int J Neuropsychopharmacol. 2010 Aug;13(7):861-76. doi: 10.1017/S1461145709990605. Epub 2009 Sep 29.

Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.

Br J Pharmacol. 2016 Jan;173(1):53-65. doi: 10.1111/bph.13333. Epub 2015 Nov 18.

Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.

Drug Alcohol Depend. 2008 Apr 1;94(1-3):191-8. doi: 10.1016/j.drugalcdep.2007.11.017.

Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.

Eur J Pharmacol. 1986 Jun 17;125(2):301-4. doi: 10.1016/0014-2999(86)90042-7.

引用本文的文献

The resurgence of synthetic cannabinoid receptor agonists as adulterants in the Era of Cannabis legalization: Lessons from prior epidemics and clinical implications.

Neurosci Biobehav Rev. 2025 Mar;170:106043. doi: 10.1016/j.neubiorev.2025.106043. Epub 2025 Feb 6.

Polycaprolactone microparticles for the subcutaneous administration of cannabidiol: in vitro and in vivo release.

Drug Deliv Transl Res. 2024 Apr;14(4):959-969. doi: 10.1007/s13346-023-01444-2. Epub 2023 Oct 12.

Nabiximols effect on blood pressure and heart rate in post-stroke patients of a randomized controlled study.

Front Cardiovasc Med. 2022 Oct 28;9:990188. doi: 10.3389/fcvm.2022.990188. eCollection 2022.

Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis.

Psychopharmacology (Berl). 2022 Nov;239(11):3731-3741. doi: 10.1007/s00213-022-06248-9. Epub 2022 Oct 13.

Δ-Tetrahydrocannabinol Differentially Alters Cannabidiol Efficacy in Recovery of Phonology and Syntax Following Damage to a Songbird Cortical-Like Brain Region.

Cannabis Cannabinoid Res. 2023 Oct;8(5):790-801. doi: 10.1089/can.2022.0073. Epub 2022 Sep 19.

Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer's disease.

Front Neurosci. 2022 Sep 2;16:962922. doi: 10.3389/fnins.2022.962922. eCollection 2022.

Sex-Dependent Prescription Patterns and Clinical Outcomes Associated With the Use of Two Oral Cannabis Formulations in the Multimodal Management of Chronic Pain Patients in Colombia.

Front Pain Res (Lausanne). 2022 Mar 24;3:854795. doi: 10.3389/fpain.2022.854795. eCollection 2022.

Impact of smoking cannabidiol (CBD)-rich marijuana on driving ability.

Forensic Sci Res. 2021 Sep 28;6(3):195-207. doi: 10.1080/20961790.2021.1946924. eCollection 2021.

Role of Caryophyllane Sesquiterpenes in the Entourage Effect of Felina 32 Hemp Inflorescence Phytocomplex in Triple Negative MDA-MB-468 Breast Cancer Cells.

Molecules. 2021 Nov 5;26(21):6688. doi: 10.3390/molecules26216688.

Mitragynine (Kratom)-Induced Cognitive Impairments in Mice Resemble Δ9-THC and Morphine Effects: Reversal by Cannabinoid CB Receptor Antagonism.

Front Pharmacol. 2021 Sep 16;12:708055. doi: 10.3389/fphar.2021.708055. eCollection 2021.

本文引用的文献

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.

Psychopharmacology (Berl). 2012 Feb;219(3):859-73. doi: 10.1007/s00213-011-2415-0. Epub 2011 Jul 28.

Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.

Psychopharmacology (Berl). 2011 Nov;218(2):443-57. doi: 10.1007/s00213-011-2342-0. Epub 2011 Jun 11.

Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study.

Neuropsychopharmacology. 2011 Jun;36(7):1340-8. doi: 10.1038/npp.2011.17. Epub 2011 Mar 16.

Subjective and physiological effects after controlled Sativex and oral THC administration.

Clin Pharmacol Ther. 2011 Mar;89(3):400-7. doi: 10.1038/clpt.2010.318. Epub 2011 Feb 2.

Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration.

Clin Chem. 2011 Jan;57(1):66-75. doi: 10.1373/clinchem.2010.152439. Epub 2010 Nov 15.

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.

Neuropsychopharmacology. 2010 Feb;35(3):764-74. doi: 10.1038/npp.2009.184. Epub 2009 Nov 18.

Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.

Arch Gen Psychiatry. 2009 Jan;66(1):95-105. doi: 10.1001/archgenpsychiatry.2008.519.

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.

Braz J Psychiatry. 2008 Sep;30(3):271-80. doi: 10.1590/s1516-44462008000300015.

Cannabinoid-induced alterations in brain disposition of drugs of abuse.

Biochem Pharmacol. 2001 Jun 1;61(11):1357-67. doi: 10.1016/s0006-2952(01)00616-5.

Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.

Braz J Med Biol Res. 1983 Jul;16(2):141-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验